Cannomed Medical Cannabis Industries

Cannomed is an Israeli medical cannabis company focused on the cultivation, distribution, and marketing of medical-grade cannabis products. Historically, the public company operated as Cannomed Medical Cannabis Industries Ltd and was listed on the Tel Aviv Stock Exchange under the symbol CNMD, with activities spanning cultivation, proprietary genetics, and downstream distribution. The company reported 17 proprietary cannabis strains and pursued a vertically integrated model that included greenhouse cultivation in Israel and plans for EU-GMP-aligned indoor capacity. Cannomed also entered a collaboration with Cannabics Pharmaceuticals to evaluate cannabis cultivars for anti-tumor potential in cancer-related applications. The former public shell was sold and renamed Geffen Residence & Renewal Ltd in January 2023, while Cannomed appears to have continued as a private cannabis operator in Israel.